Topics

Biocept changing the way physicians examine blood work for their cancer patients

09:10 EDT 25 Jul 2019 | Proactive Investors

The San Diego-based company has developed a patented liquid biopsy technology called Target Selector that detects and isolates cancer biomarkers such as circulating tumor cells and cell-free circulating tumor DNA

Original Article: Biocept changing the way physicians examine blood work for their cancer patients

NEXT ARTICLE

More From BioPortfolio on "Biocept changing the way physicians examine blood work for their cancer patients"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...